| Group one middle age population age < 65 years old (n = 34) | Group two elderly population age > 65 years old (n = 34) | P value |
Age (years) | 55 ± 4.4 | 71 ± 4.7 | 0.000 |
Male/female | 24/10 | 23/11 | 0.801 |
BMI (kg/m2) | 25 ± 3.1 | 24 ± 2.8 | 0.182 |
Hypertension (%) | 15 (44) | 20 (58) | 0.282 |
Diabetes mellitus (%) | 9 (26) | 5 (14) | 0.254 |
Smoking (%) | 15 (44) | 18 (52) | 0.447 |
EF (%) | 60.3 ± 8.8 | 61.3 ± 7.4 | 0.660 |
Aspirin use (%) | 24 (71) | 17 (50) | 0.109 |
Beta-blockers’ use (%) | 14 (41) | 12 (35) | 0.624 |
ACE inhibitors’ use (%) | 3 (8) | 6 (17) | 0.325 |
CCB use (%) | 8 (23) | 14 (41) | 0.160 |
Statins use (%) | 19 (55) | 17 (50) | 0.600 |
Nitrate use (%) | 17 (50) | 21 (61) | 0.353 |
SBP (mmHg) | 123.4 ± 17.6 | 128.5 ± 19.4 | 0.254 |
DBP (mmHg) | 74.8 ± 12.2 | 71.8 ± 11.9 | 0.193 |